National Health Investors Inc (NHI) Receives Consensus Recommendation of “Hold” from Brokerages

Share on StockTwits

National Health Investors Inc (NYSE:NHI) has earned an average recommendation of “Hold” from the nine ratings firms that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $78.20.

A number of equities analysts recently issued reports on the stock. Zacks Investment Research lowered shares of National Health Investors from a “hold” rating to a “sell” rating in a research report on Tuesday. SunTrust Banks increased their target price on shares of National Health Investors to $85.00 and gave the company a “neutral” rating in a research report on Wednesday, February 20th. They noted that the move was a valuation call. BMO Capital Markets lowered shares of National Health Investors from a “market perform” rating to an “underperform” rating and set a $78.00 target price for the company. in a research report on Wednesday, February 20th. KeyCorp set a $65.00 target price on shares of National Health Investors and gave the company a “sell” rating in a research report on Thursday, December 20th. Finally, ValuEngine upgraded shares of National Health Investors from a “hold” rating to a “buy” rating in a research report on Tuesday, December 11th.

In other National Health Investors news, Director Robert A. Mccabe, Jr. sold 1,181 shares of the company’s stock in a transaction dated Thursday, February 21st. The shares were sold at an average price of $78.04, for a total value of $92,165.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 5.63% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of NHI. Russell Investments Group Ltd. lifted its holdings in National Health Investors by 16.3% in the 3rd quarter. Russell Investments Group Ltd. now owns 33,606 shares of the real estate investment trust’s stock valued at $2,540,000 after acquiring an additional 4,710 shares during the last quarter. Wells Fargo & Company MN lifted its stake in National Health Investors by 1.8% during the third quarter. Wells Fargo & Company MN now owns 152,385 shares of the real estate investment trust’s stock valued at $11,519,000 after buying an additional 2,721 shares in the last quarter. Meeder Asset Management Inc. lifted its stake in National Health Investors by 1,298.1% during the third quarter. Meeder Asset Management Inc. now owns 3,020 shares of the real estate investment trust’s stock valued at $228,000 after buying an additional 2,804 shares in the last quarter. Cambridge Investment Research Advisors Inc. lifted its stake in National Health Investors by 23.3% during the third quarter. Cambridge Investment Research Advisors Inc. now owns 7,390 shares of the real estate investment trust’s stock valued at $559,000 after buying an additional 1,395 shares in the last quarter. Finally, HL Financial Services LLC lifted its stake in National Health Investors by 8.3% during the third quarter. HL Financial Services LLC now owns 11,708 shares of the real estate investment trust’s stock valued at $885,000 after buying an additional 900 shares in the last quarter. 70.77% of the stock is owned by institutional investors.

Shares of NHI opened at $79.24 on Friday. The stock has a market capitalization of $3.37 billion, a P/E ratio of 14.46 and a beta of 0.51. The company has a debt-to-equity ratio of 0.92, a current ratio of 17.92 and a quick ratio of 17.92. National Health Investors has a 52-week low of $65.10 and a 52-week high of $84.57.

National Health Investors (NYSE:NHI) last announced its earnings results on Tuesday, February 19th. The real estate investment trust reported $0.87 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.39 by ($0.52). The company had revenue of $74.00 million during the quarter, compared to the consensus estimate of $75.16 million. National Health Investors had a net margin of 52.38% and a return on equity of 11.36%. The business’s quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.35 EPS. Equities research analysts expect that National Health Investors will post 5.5 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Friday, March 29th will be issued a $1.05 dividend. This represents a $4.20 dividend on an annualized basis and a yield of 5.30%. This is an increase from National Health Investors’s previous quarterly dividend of $1.00. The ex-dividend date is Thursday, March 28th. National Health Investors’s dividend payout ratio is presently 72.99%.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

See Also: Fundamental Analysis

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Nectar  Price Hits $0.17 on Major Exchanges
Nectar Price Hits $0.17 on Major Exchanges
NCS Multistage Holdings Inc  Receives Average Rating of “Hold” from Brokerages
NCS Multistage Holdings Inc Receives Average Rating of “Hold” from Brokerages
MyBit  Trading Down 2.3% Over Last 7 Days
MyBit Trading Down 2.3% Over Last 7 Days
Hubbell Incorporated  Insider Kevin Arthur Poyck Sells 247 Shares
Hubbell Incorporated Insider Kevin Arthur Poyck Sells 247 Shares
Weekly Analysts’ Ratings Updates for Canfor Pulp Products
Weekly Analysts’ Ratings Updates for Canfor Pulp Products
AC3  Price Reaches $0.0052 on Top Exchanges
AC3 Price Reaches $0.0052 on Top Exchanges


 
© 2006-2019 Zolmax.